Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the functions of five recently characterized lncRNAs in cancer progression. | Clin Transl Oncol | 2025 | 39066874 | PubTator, text mining | PubMed |
| Identification and characterisation of a novel EhOrc1/Cdc6 from the human pathogen Entamoeba histolytica: an in silico approach. | J Biomol Struct Dyn | 2025 | 38095553 | PubTator, text mining | PubMed |
| The bioinformatics analysis and experimental validation of the carcinogenic role of EXO1 in lung adenocarcinoma. | Front Oncol | 2024 | 39777332 | PubTator, text mining | PubMed |
| RNA Sequencing and Weighted Gene Co-Expression Network Analysis Highlight DNA Replication and Key Genes in Nucleolin-Depleted Hepatoblastoma Cells. | Genes (Basel) | 2024 | 39766782 | PubTator, text mining | PubMed |
| Exploring Bioinformatics Tools to Analyze the Role of CDC6 in the Progression of Polycystic Ovary Syndrome to Endometrial Cancer by Promoting Immune Infiltration. | Int J Mol Sci | 2024 | 39684684 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| MCM double hexamer loading visualized with human proteins. | Nature | 2024 | 39604733 | PubTator, text mining | PubMed |
| Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma. | Int J Mol Sci | 2024 | 39596041 | PubTator, text mining | PubMed |
| Statistical inference with a manifold-constrained RNA velocity model uncovers cell cycle speed modulations. | Nat Methods | 2024 | 39482463 | PubTator, text mining | PubMed |
| Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction. | Clin Exp Med | 2024 | 39470826 | PubTator, text mining | PubMed |
| Integrated network pharmacology and transcriptomic approach reveal the role of equol in reducing colorectal cancer via regulating multiple cell cycle genes in HCT116 cells. | Int J Biol Macromol | 2024 | 39461627 | PubTator, text mining | PubMed |
| Construction of a novel model based on PVT1-MYC duet-related genes for predicting survival and characterization of the tumor microenvironment in pancreatic cancer. | Front Immunol | 2024 | 39376555 | PubTator, text mining | PubMed |
| Selection of Reference Genes in Siraitia siamensis and Expression Patterns of Genes Involved in Mogrosides Biosynthesis. | Plants (Basel) | 2024 | 39273933 | PubTator, text mining | PubMed |
| Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer. | Transl Cancer Res | 2024 | 39262459 | PubTator, text mining | PubMed |
| A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins. | iScience | 2024 | 39184446 | PubTator, text mining | PubMed |
| Combination of AID2 and BromoTag expands the utility of degron-based protein knockdowns. | EMBO Rep | 2024 | 39179892 | PubTator, text mining | PubMed |
| Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA Replication. | Cancer Res | 2024 | 39120597 | PubTator, text mining | PubMed |
| CDC6 overexpression contributes to the malignant phenotype of glioma via IL6/JAK2/STAT3 signaling. | Am J Cancer Res | 2024 | 39113855 | PubTator, text mining | PubMed |
| Muscle Transcriptome Analysis of Mink at Different Growth Stages Using RNA-Seq. | Biology (Basel) | 2024 | 38785766 | PubTator, text mining | PubMed |
| Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments. | Nutr Cancer | 2024 | 38721626 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=6